Induction of TGF-β1 by the matricellular protein SPARC in a rat model of glomerulonephritis

Kidney International

Volumn 57, Issue 1, 2000, Pages 117-128

  Bassuk, James A ^a   Pichler, Raimund ^a   Rothmier, Justin D ^a   Pippen, Jeffrey ^a   Gordon, Kathy ^a   Meek, Rick L ^a   Bradshaw, Amy D ^a   Lombardi, Donna ^a   Strandjord, Thomas P ^a   Reed, May ^a   Sage, E Helene ^a   Couser, William G ^a   Johnson, Richard ^a  

^a UNIVERSITY OF WASHINGTON SCHOOL OF MEDICINE   (United States)

Author keywords

Anti thymocyte serum; Cell proliferation; Collagen type 1; Extracellular matrix; Renal disease; Thy 1

Indexed keywords

COLLAGEN TYPE 1; OSTEONECTIN; RECOMBINANT PROTEIN; THYMOCYTE ANTIBODY; TRANSFORMING GROWTH FACTOR BETA1; MESSENGER RNA; TRANSFORMING GROWTH FACTOR BETA;

ANIMAL CELL; ARTICLE; CELL DAMAGE; CELL PROLIFERATION; EXTRACELLULAR MATRIX; GLOMERULONEPHRITIS; GLOMERULUS; KIDNEY DISEASE; MESANGIUM CELL; NEPHRITIS; NONHUMAN; PRIORITY JOURNAL; PROTEIN LOCALIZATION; RAT; ANIMAL; BIOSYNTHESIS; CELL CULTURE; DISEASE MODEL; GENETICS; IMMUNOHISTOCHEMISTRY; MALE; METABOLISM; PHYSIOLOGY; SPRAGUE DAWLEY RAT; WISTAR RAT;

ANIMALS; CELLS, CULTURED; DISEASE MODELS, ANIMAL; GLOMERULONEPHRITIS; IMMUNOHISTOCHEMISTRY; MALE; OSTEONECTIN; RATS; RATS, SPRAGUE-DAWLEY; RATS, WISTAR; RECOMBINANT PROTEINS; RNA, MESSENGER; TRANSFORMING GROWTH FACTOR BETA;

EID: 0033621614     PISSN: 00852538     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1523-1755.2000.00811.x     Document Type: Article

References (56)

1. 1. Bornstein P: Diversity of function is inherent in matricellular proteins: An appraisal of thrombospondin 1. J Cell Biol 130:503-506, 1995
2. 2. Sage EH, Bornstein P: Extracellular proteins that modulate cell-matrix interactions: SPARC, tenascin, and thrombospondin. J Biol Chem 266:14831-14834, 1991
3. 3. Lane TF, Sage EH: The biology of SPARC, a protein that modulates cell-matrix interactions. Fed Am Soc Exp Biol J 8:163-173, 1994
4. 4. Iruela-Arispe ML, Vernon RB, Wu H, Jaenisch R, Sage EH: Type I collagen-deficient Mov-13 mice do not retain SPARC in the extracellular matrix: Implications for fibroblast function. Dev Dyn 207:171-183, 1996
5. 5. Crawford SE, Stellmach V, Murphyullrich JE, Ribeiro S-MF, Lawler J, Hynes RO, Boivin GP, Bouck N: Thrombospondin-1 is a major activator of TGF-beta 1 in vivo. Cell 93:1159-1170, 1998
6. +2-binding glycoprotein SPARC modulates cell cycle progression in bovine aortic endothelial cells. Proc Natl Acad Sci USA 88:2648-2652, 1991
7. 7. Goldblum SE, Ding X, Funk SE, Sage EH: SPARC (secreted protein acidic and rich in cysteine) regulates endothelial cell shape and barrier function. Proc Natl Acad Sci USA 91:3448-3452, 1994
8. 8. Rosenblatt S, Bassuk JA, Alpers CE, Sage EH, Timpl R, Preissner KT: Differential modulation of cell adhesion by interaction between adhesive and counteradhesive proteins: Characterization of the binding of vitronectin to osteonectin (BM 40, SPARC). Biochem J 324:311-319, 1997
9. 9. Pichler RH, Hugo CH, Shankland SJ, Reed MJ, Bassuk JA, Andoh TF, Lombardi DM, Schwartz SM, Bennett WM, Alpers CE, Sage EH, Couser WG, Johnson RJ: SPARC is expressed in renal interstitial fibrosis and in renal vascular injury. Kidney Int 50:1978-1989, 1996
10. 10. Pichler RH, Bassuk JA, Hugo C, Reed MJ, Eng E, Gordon KL, Pippin J, Alpers CA, Couser WG, Sage EH, Johnson RJ: SPARC is expressed by mesangial cells in experimental mesangial proliferative nephritis and inhibits PDGF-mediated mesangial cell proliferation in vitro. Am J Pathol 148:1153-1167, 1996
11. 11. Shankland SJ, Floege J, Thomas SE, Nangaku M, Hugo C, Pippin J, Henne K, Hockenberry DM, Johnson RJ, Couser WG: Cyclin kinase inhibitors are increased during experimental membranous nephropathy: Potential role in limiting glomerular epithelial cell proliferation in vivo. Kidney Int 52:404-413, 1997
12. 12. Mundel P, Heid HW, Mundel TM, Kruger M, Reiser J, Kriz W: Synaptopodin: An actin-associated protein in telencephalic dendrites and renal podocytes. J Cell Biol 139:193-197, 1997
13. 13. Floege J, Alpers CE, Sage EH, Pritzl P, Gordon K, Johnson RJ, Couser WG: Markers of complement-dependent and complement-independent glomerular visceral epithelial cell injury in vivo: Expression of antiadhesive proteins and cytoskeletal changes. Lab Invest 67:486-497, 1992
14. 14. Kriz W: Progressive renal failure: Inability of podocytes to replicate and the consequences for development of glomerulosclerosis. Nephrol Dial Transplant 11:1738-1742, 1996
15. 15. Gilbert RE, McNally PG, Cox A, Dziadek M, Rumble J, Cooper ME, Jerums G: SPARC gene expression is reduced in early diabetes-related kidney growth. Kidney Int 48:1216-1225, 1995
16. 16. Floege J, Johnson RJ, Gordon K, Iida H, Pritzl P, Yoshimura A, Campbell C, Alpers CE, Couser WG: Increased synthesis of extracellular matrix in mesangial proliferative nephritis. Kidney Int 40:477-488, 1991
17. 17. Border WA: Transforming growth factor-beta and the pathogenesis of glomerular diseases. Curr Opin Nephrol Hypertens 3:54-58, 1994
18. 18. Minto AW, Fogel MA, Natori Y, O'Meara YM, Abrahamson DR, Smith B, Salant DJ: Expression of type I collagen mRNA in glomeruli of rats with passive Heymann nephritis. Kidney Int 43:121-127, 1993
19. 19. Shankland SJ, Pippin J, Pichler RH, Gordon KL, Friedman S, Gold LI, Johnson RJ, Couser WG: Differential expression of transforming growth factor-beta isoforms and receptors in experimental membranous nephropathy. Kidney Int 50:116-124, 1996
20. 20. Hugo C, Shankland SJ, Pichler RH, Couser WG, Johnson RJ: Thrombospondin 1 precedes and predicts the development of tubulointerstitial fibrosis in glomerular disease in the rat. Kidney Int 53:302-311, 1998
21. 21. Adler S, Baker PJ, Johnson RJ, Ochi RF, Pritzl P, Couser WG: Complement membrane attack complex stimulates production of reactive oxygen metabolites by cultured rat mesangial cells. J Clin Invest 77:762-770, 1986
22. 22. Bassuk JA, Braun LP, Motamed K, Baneyx F, Sage EH: Renaturation of SPARC from E. coli requires isomerization of disulfide bonds for recovery of biological activity. Int J Biochem Cell Biol 28:1031-1043, 1996
23. 23. Bassuk JA, Baneyx F, Vernon RB, Funk SE, Sage EH: Expression of biologically active human SPARC from Escherichia coli. Arch Biochem Biophys 325:8-19, 1996
24. +2-binding sites modulate cell shape. J Cell Biol 111:3065-3076, 1990
25. 25. Young NS, Levin J, Prendergast RA: An invertebrate coagulation system activated by endotoxin: Evidence for enzymatic mechanism. J Clin Invest 51:1790-1796, 1972
26. 26. Iruela Arispe ML, Porter P, Bornstein P, Sage EH: Thrombospondin-1, an inhibitor of angiogenesis, is regulated by progesterone in the human endometrium. J Clin Invest 97:403-412, 1996
27. 27. Ruoslahti E, Hayman EG, Pierschbacher M, Engvall E: Fibronectin: Purification, immunochemical properties, and biological activities. Methods Enzymol 82:803-831, 1982
28. 28. Duijvestijn AMGH, Klatter F, Van Majoor GDBE, Van-Breda-Vriesman PJ: Antibodies defining rat endothelial cells: RECA-1, a pan-endothelial cell-specific monoclonal antibody. Lab Invest 66:459-466, 1992
29. 29. Kliem V, Johnson RJ, Alpers CE, Yoshimura A, Couser WG, Koch K, Floege J: Mechanisms involved in the pathogenesis of tubulointerstitial fibrosis in 5/6-nephrectomized rats. Kidney Int 49:666-678, 1996
30. 30. Hugo C, Pichler R, Gordon K, Schmidt R, Amieva M, Couser WG, Furthmayr H, Johnson RJ: The cytoskeletal linking proteins, moesin and radixin, are upregulated by platelet-derived growth factor, but not basic fibroblast growth factor in experimental mesangial proliferative glomerulonephritis. J Clin Invest 97:2499-2508, 1996
31. 31. Danielpour D, Dart LL, Flanders KC, Roberts AB, Sporn MB: Immunodetection and quantitation of the two forms of transforming growth factor-beta (TGF-beta 1 and TGF-beta 2) secreted by cells in culture. J Cell Physiol 138:79-86, 1989
32. 32. Wells RG, Yankelev H, Lin HY, Lodish HF: Biosynthesis of the type I and type II TGF-beta receptors: Implications for complex formation. J Biol Chem 272:11444-11451, 1997
33. 33. Yamamoto T, Wilson CB: Quantitative and qualitative studies of antibody-induced mesangial cell damage in the rat. Kidney Int 32:514-525, 1987
34. 34. Johnson RJ, Raines EW, Floege J, Yoshimura A, Pritzl P, Alpers C, Ross R: Inhibition of mesangial cell proliferation and matrix expansion in glomerulonephritis in the rat by antibody to platelet-derived growth factor. J Exp Med 175:1413-1416, 1992
35. 35. Okuda S, Languino LR, Ruoslahti E, Border WA: Elevated expression of transforming growth factor-beta and proteoglycan production in experimental glomerulonephritis: Possible role in expansion of the mesangial extracellular matrix. J Clin Invest 86:453-462, 1990
36. 36. Yamamoto T, Noble NA, Miller DE, Border WA: Sustained expression of TGF-beta 1 underlies development of progressive kidney fibrosis. Kidney Int 45:916-927, 1994
37. 37. Van Dixhoorn MGA, Salazar-Exaire D, Sato T, Daha MR, Quigg RJ, Bruijn JA, Couser WG, De Heer E: Anti-vitronectin antibodies enhance anti-Thy-1-induced proteinuria in PVG/c, but not in Wistar rats. J Am Soc Nephrol 9:994-1007, 1998
38. 38. Hohenadl C, Mann K, Mayer U, Timpl R, Paulsson M, Aeschlimann D: Two adjacent N-terminal glutamines of BM-40 (osteonectin, SPARC) act as amine acceptor sites in transglutaminase C-catalyzed modification. J Biol Chem 270:23415-23420, 1995
39. 39. Gooden M, Vernon RB, Bassuk JA, Sage EH: Cell cycle-dependent location of the matricellular protein SPARC. J Cell Biochem 74:152-167, 1999
40. +2-binding module in BM-40/SPARC/osteonectin. Nat Med 3:67-72, 1996
41. 41. Sumitomo S, Inouye S, Liu X, Ling N, Shimasaki S: The heparin binding site of follistatin is involved in its interaction with activin. Biochem Biophys Res Commun 208:1-9, 1995
42. 42. Sage EH, Johnson C, Bornstein P: Characterization of a novel serum albumin-binding glycoprotein secreted by endothelial cells in culture. J Biol Chem 259:3993-4007, 1984
43. 43. Hohenester E, Maurer R, Timpl R: Crystal structure of a pair of follistatin-like and EF-hand calcium-binding domains in BM-40. EMBO J 16:3778-3786, 1997
44. 44. Floege J, Eng E, Young BA, Couser WG, Johnson RJ: Heparin suppresses mesangial cell proliferation and matrix expansion in experimental mesangioproliferative glomerulonephritis. Kidney Int 43:369-380, 1993
45. 45. Isaka Y, Fujiwara Y, Ueda N, Kaneda Y, Kamada T, Imai E: Glomerulosclerosis induced by in vivo transfection of transforming growth factor-beta or platelet-derived growth factor gene into the rat kidney. J Clin Invest 92:2597-2601, 1993
46. 46. Border WA, Okuda S, Languino LR, Sporn MB, Ruoslahti E: Suppression of experimental glomerulonephritis by antiserum against transforming growth factor beta 1. Nature 346:371-374, 1990
47. 47. Border WA, Noble NA, Yamamoto T, Harper JR, Yamaguchi Y, Pierschbacher MD, Ruoslahti E: Natural inhibitor of transforming growth factor-beta protects against scarring in experimental kidney disease. Nature 360:361-364, 1992
48. 48. Eng E, Floege J, Young BA, Couser WG, Johnson RJ: Does extracellular matrix expansion in glomerular disease require mesangial cell proliferation? Kidney Int 45(Suppl):S45-S47, 1994
49. 49. Shultz PJ, Dicorleto PE, Silver BJ, Abboud HE: Mesangial cells express PDGF mRNAs and proliferate in response to PDGF. Am J Physiol 255:t-84, 1988
50. 50. Hugo C, Pichler R, Meek R, Gordon K, Kyriakides T, Floege J, Bornstein P, Couser WG, Johnson RJ: Thrombospondin 1 is expressed by proliferating mesangial cells and is up-regulated by PDGF and bFGF in vivo. Kidney Int 48:1846-1856, 1995
51. 51. Kojima S, Nara K, Rifkin DB: Requirement for transglutaminase in the activation of latent transforming growth factor-beta in bovine endothelial cells. J Cell Biol 121:439-448, 1993
52. 52. Nunes I, Gleizes PE, Metz CN, Rifkin DB: Latent transforming growth factor-beta binding protein domains involved in activation and transglutaminase-dependent cross-linking of latent transforming growth factor-beta. J Cell Biol 136:1151-1163, 1997
53. 53. Lane TF, Iruela Arispe ML, Sage EH: Regulation of gene expression by SPARC during angiogenesis in vitro: Changes in fibronectin, thrombospondin-1, and plasminogen activator inhibitor-1. J Biol Chem 267:16736-16745, 1992
54. 54. Yost JC, Sage EH: Specific interaction of SPARC with endothelial cells is mediated through a carboxyl-terminal sequence containing a calcium-binding EF hand. J Biol Chem 268:25790-25796, 1993
55. +2-binding EF-hand sequence. J Cell Biochem 57:127-140, 1995
56. +2-binding EF-hand. J Cell Biochem 57:341-350, 1995